195 related articles for article (PubMed ID: 32764529)
21. [RHD variant in RhD/-/ mother with anti-D makes noninvasive fetal RHD genotyping impossible].
Orzińska A; Engel K; Łakomy M; Smolarczyk-Wodzyńska J; Lipińska A; Pelc-Kłopotowska M; Brojer E
Ginekol Pol; 2009 Oct; 80(10):786-90. PubMed ID: 19943546
[TBL] [Abstract][Full Text] [Related]
22. Fetal RHD Genotyping Using Real-Time Polymerase Chain Reaction Analysis of Cell-Free Fetal DNA in Pregnancy of RhD Negative Women in South of Iran.
Moezzi L; Keshavarz Z; Ranjbaran R; Aboualizadeh F; Behzad-Behbahani A; Abdullahi M; Ramezani A; Samsami A; Sharifzadeh S
Int J Fertil Steril; 2016; 10(1):62-70. PubMed ID: 27123202
[TBL] [Abstract][Full Text] [Related]
23. Reliable Determination of Fetal RhD Status by RHD Genotyping from Maternal Plasma.
Dovč-Drnovšek T; Klemenc P; Toplak N; Blejec T; Bricl I; Rožman P
Transfus Med Hemother; 2013 Feb; 40(1):37-43. PubMed ID: 23637648
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.
Papasavva T; Martin P; Legler TJ; Liasides M; Anastasiou G; Christofides A; Christodoulou T; Demetriou S; Kerimis P; Kontos C; Leontiades G; Papapetrou D; Patroclos T; Phylaktou M; Zottis N; Karitzie E; Pavlou E; Kountouris P; Veldhuisen B; van der Schoot E; Kleanthous M
BMC Res Notes; 2016 Apr; 9():198. PubMed ID: 27036548
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of Non-Invasive Fetal RHD Genotyping towards Immunoprophylaxis Optimization.
Blanco S; Giacomi VS; Slobodianiuk LG; Frutos MC; Carrizo LH; Fanin GE; Culasso JM; Gallego SV
Transfus Med Hemother; 2018 Nov; 45(6):423-428. PubMed ID: 30800032
[No Abstract] [Full Text] [Related]
26. Noninvasive fetal RhD genotyping from maternal blood.
Kolialexi A; Tounta G; Mavrou A
Expert Rev Mol Diagn; 2010 Apr; 10(3):285-96. PubMed ID: 20370586
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic accuracy of fetal rhesus D genotyping using cell-free fetal DNA during the first trimester of pregnancy.
Vivanti A; Benachi A; Huchet FX; Ville Y; Cohen H; Costa JM
Am J Obstet Gynecol; 2016 Nov; 215(5):606.e1-606.e5. PubMed ID: 27393271
[TBL] [Abstract][Full Text] [Related]
28. Non-invasive prenatal rhesus D genotyping using cell-free foetal DNA.
Rather RA; Dhawan V; Saha SC
Indian J Med Res; 2019 Jul; 150(1):62-66. PubMed ID: 31571630
[TBL] [Abstract][Full Text] [Related]
29. Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation.
Akolekar R; Finning K; Kuppusamy R; Daniels G; Nicolaides KH
Fetal Diagn Ther; 2011; 29(4):301-6. PubMed ID: 21212654
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma.
Grootkerk-Tax MG; Soussan AA; de Haas M; Maaskant-van Wijk PA; van der Schoot CE
Transfusion; 2006 Dec; 46(12):2142-8. PubMed ID: 17176327
[TBL] [Abstract][Full Text] [Related]
31. Prenatal genotyping of RHD and SRY using maternal blood.
Randen I; Hauge R; Kjeldsen-Kragh J; Fagerhol MK
Vox Sang; 2003 Nov; 85(4):300-6. PubMed ID: 14633256
[TBL] [Abstract][Full Text] [Related]
32. First trimester noninvasive fetal RHD genotyping using maternal dried blood spots.
Xiong Y; Jeronis S; Hoffman B; Liebermann DA; Geifman-Holtzman O
Prenat Diagn; 2017 Apr; 37(4):311-317. PubMed ID: 28081297
[TBL] [Abstract][Full Text] [Related]
33. Noninvasive Prenatal Diagnosis of Fetal RHD Status Using Cell-free Fetal DNA in Maternal Plasma.
Ahmadi MH; Pourfathollah AA; Rabiee M; Amirizadeh N
J Reprod Infertil; 2022; 23(2):128-134. PubMed ID: 36043134
[TBL] [Abstract][Full Text] [Related]
34. RHD genotyping from maternal plasma: guidelines and technical challenges.
Avent ND
Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
[TBL] [Abstract][Full Text] [Related]
35. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service.
Finning KM; Martin PG; Soothill PW; Avent ND
Transfusion; 2002 Aug; 42(8):1079-85. PubMed ID: 12385421
[TBL] [Abstract][Full Text] [Related]
36. Fetal Sex and RHD Genotyping with Digital PCR Demonstrates Greater Sensitivity than Real-time PCR.
Sillence KA; Roberts LA; Hollands HJ; Thompson HP; Kiernan M; Madgett TE; Welch CR; Avent ND
Clin Chem; 2015 Nov; 61(11):1399-407. PubMed ID: 26354802
[TBL] [Abstract][Full Text] [Related]
37. Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women.
Rouillac-Le Sciellour C; Puillandre P; Gillot R; Baulard C; Métral S; Le Van Kim C; Cartron JP; Colin Y; Brossard Y
Mol Diagn; 2004; 8(1):23-31. PubMed ID: 15230639
[TBL] [Abstract][Full Text] [Related]
38. Fetal RHD detection from circulating cell-free fetal DNA in maternal plasma: validation of a diagnostic kit using automatic extraction and frozen DNA.
Londero D; Stampalija T; Bolzicco D; Castro Silva E; Candolini M; Cortivo C; Dreossi C; Fantasia I; Pecile V; De Angelis V
Transfus Med; 2019 Dec; 29(6):408-414. PubMed ID: 31209986
[TBL] [Abstract][Full Text] [Related]
39. Genotyping approach for non-invasive foetal RHD detection in an admixed population.
Boggione CT; Luján Brajovich ME; Mattaloni SM; Di Mónaco RA; García Borrás SE; Biondi CS; Cotorruelo CM
Blood Transfus; 2017 Jan; 15(1):66-73. PubMed ID: 27136427
[TBL] [Abstract][Full Text] [Related]
40. Fetal blood group genotyping: present and future.
Daniels G; Finning K; Martin P; Summers J
Ann N Y Acad Sci; 2006 Sep; 1075():88-95. PubMed ID: 17108196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
